Phase
Condition
Anxiety Disorders
Kleptomania
Obsessive-compulsive Disorder
Treatment
Cannabidiol
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men and women age 18-65
Primary diagnosis of OCD, Hoarding Disorder, Skin Picking Disorder,Trichotillomania, or Tourette Syndrome
YBOCS score of at least 18 at baseline
Ability to understand and sign the consent form.
Exclusion
Exclusion Criteria:
Unstable medical illness based on history or clinically significant abnormalities onbaseline physical examination or labs
Current pregnancy or lactation, or inadequate contraception in women of childbearingpotential
Subjects considered an immediate suicide risk based on the Columbia Suicide SeverityRating Scale (C-SSRS)
Past 12-month DSM-5 psychiatric disorder other than OCD
Illegal substance use based on urine toxicology screening
Initiation of psychological interventions within 3 months of screening
Use of any other psychotropic medication
Previous treatment with Epidiolex
Cognitive impairment that interferes with the capacity to understand andself-administer medication or provide written informed consent
Study Design
Study Description
Connect with a study center
University of Chicago
Chicago, Illinois 60637
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.